SCHEMBL23926949

SCHEMBL23926949

COc1ccc(CC(=O)O)c(C(=O)O)c1.COc1ccc2c(c1)C(=O)N(C)C(=O)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 3/20 0.48
GAA P10253 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CASP1 P29466 1/20 0.43
HSD17B10 Q99714 2/20 0.41
LCK P06239 1/20 0.38
METAP1 P53582 1/20 0.38
POLB P06746 3/20 0.38
TNF P01375 2/20 0.37
AKR1C2 P52895 2/20 0.37
ESR1 P03372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922254 0.81 ALDH1A1 (0.63) KDM4EALDH1A1HPGDGAACYP1A2
SCHEMBL1399960 0.79 HSD17B10 (0.63) KDM4EALDH1A1SMN1; SMN2HSD17B10LCK
SCHEMBL9922257 0.73 METAP1 (0.55) KDM4EALDH1A1HPGDGAACYP1A2
SCHEMBL11774872 0.69 SMN1; SMN2 (0.53) KDM4EALDH1A1HPGDCYP3A4L3MBTL1
SCHEMBL7314126 0.69 HSD17B10 (0.61) KDM4EALDH1A1HPGDGAACYP3A4
SCHEMBL6882571 0.68 POLB (0.69) KDM4EALDH1A1HPGDGAACYP1A2
SCHEMBL744543 0.68 HSD17B10 (0.68) KDM4ESMN1; SMN2HSD17B10LCKPOLB
SCHEMBL13469239 0.67 SMN1; SMN2 (0.57) KDM4EALDH1A1HPGDGAAL3MBTL1
SCHEMBL26679226 0.67 POLB (0.59) KDM4EALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL13495344 0.67 ALDH1A1 (0.62) KDM4EALDH1A1HPGDGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901149-A1 IMPURITIES OF AMIDE DERIVATIVES AND USE THEREOF NHWA Pharma Corporation (CN) 2021-10-27 EP disclosed